Chinese Ostomy Collaboration Group (COCG) Clinical Study -SITI Classification

Summary

Colorectal cancer is an important cancer worldwide, and its incidence is increasing year by year. A large proportion of patients may require diverting stoma or even permanent stoma after surgery. Some of these patients will have a variety of stoma-related complications, which seriously affect the quality of life of patients. At present, the mainstream postoperative complication classification is the traditional CD classification, which is suitable for the classification of most postoperative complications. However, due to the unique anatomical characteristics of patients with stoma, the current CD classification system may not be suitable for the classification of patients with stoma-related complications. Therefore, we plan to establish a registry database of colorectal cancer patients with stoma, explore the attribution and incidence of stoma-related complications, and propose a new improved classification system, the SITI classification, on the existing CD classification, for verification and promotion.

Conditions

• Complication,Postoperative
• Stoma

Interventions

DIAGNOSTIC_TEST

Novel severity grading system of stoma-related complication in cancer patients

Over 5000 stoma patients treated at 26 centers between 2022 and 2023 were classified according to SITI-CD Classification.

Sponsors & Collaborators

• Beijing Chao Yang Hospital

  collaborator OTHER

• Peking University Third Hospital

  collaborator OTHER

• Peking University First Hospital

  collaborator OTHER

• Peking University People's Hospital

  collaborator OTHER

• Peking Union Medical College Hospital

  collaborator OTHER

• Beijing New Journey Cancer Hospital

  collaborator UNKNOWN

• Beijing Nanjiao Tumor Hospital

  collaborator UNKNOWN

• Xuanwu Hospital, Beijing

  collaborator OTHER

• Beijing Hospital

  collaborator OTHER_GOV

• Hebei medical college fourth hospital

  collaborator UNKNOWN

• China-Japan Union Hospital, Jilin University

  collaborator OTHER

• Jiangsu Province people hospital

  collaborator UNKNOWN

• Jinzhou Medical University

  collaborator OTHER

• Shanxi Province Cancer Hospital

  collaborator OTHER

• Ruijin Hospital

  collaborator OTHER

• Changhai Hospital

  collaborator OTHER

• The Second Affiliated Hospital of Suzhou Medical University

  collaborator UNKNOWN

• Tianjin People's Hospital

  collaborator OTHER

• Yantai Yuhuangding Hospital

  collaborator OTHER

• First Affiliated Hospital of Zhejiang University

  collaborator OTHER

• Zhejiang cancer University

  collaborator UNKNOWN

• China-Japan Friendship Hospital

  collaborator OTHER

• Sixth Affiliated Hospital, Sun Yat-sen University

  collaborator OTHER

• Affiliated Drum Tower Hospital, Nanjing University

  collaborator UNKNOWN

• Peking University Cancer Hospital & Institute

  lead OTHER

Principal Investigators

• LIN WANG · Peking University Cancer Hospital & Institute

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-08-15

Primary Completion

2025-12-15

Completion

2025-12-15

Countries

• China

Study Locations